MassimoS.FiandacaMDMBA, FAANS, FACS

Executive Vice President, Therapeutic Strategies - CNS Gene Therapy - Asklepios BioPharmaceuticals, Inc.

Dr. Fiandaca is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
Asklepios BioPharmaceutical Inc - CNS Gene Therapy
2447 North Star Rd
Upper Arlington, OH 43221
Phone+1 510-358-8431

Neurosurgeon, neuroscientist, and entrepreneur working in biotechnology company focused on vector-based gene therapy strategies and direct brain delivery technologies for human central nervous system disorders.
Current Specialties: CNS gene therapy; convection enhanced delivery (CED); neurosurgical methods and devices; translational neuroscience research; blood-based biomarkers.

Loyola University of Maryland, Sellinger School of Business and ManagementMBA, Business and Management, Beta Gamma Sigma, 1999 - 2001
University of Rochester Medical CenterFellowship, Neurobiology and Anatomy, 1987 - 1988
Emory University School of MedicineResidency, Neurological Surgery, 1982 - 1987
Emory University School of MedicineInternship, Surgery, 1981 - 1982
Oregon Health and Science University School of MedicineClass of 1981, MD, Alpha Omega Alpha
Oregon State UniversityBS, Zoology, 1973 - 1977

PubMed

18 citations
Long-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of individuals with Parkinson's disease.
Matthew T Rocco, Asad S Akhter, Debra J Ehrlich, Gretchen C Scott, Codrin Lungu
Molecular Therapy. 2022-12-07
17 citations
A retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer's disease.
Fabio Macciardi, Maria Giulia Bacalini, Ricardo Miramontes, Alessio Boattini, Cristian Taccioli
Geroscience. 2022-06-01
11 citations
TGFβ Drives Metabolic Perturbations during Epithelial Mesenchymal Transition in Pancreatic Cancer: TGFβ Induced EMT in PDAC.
Meena U Rajagopal, Shivani Bansal, Prabhjit Kaur, Shreyans K Jain, Tatiana Altadil
Cancers. 2021-12-09

Journal Articles

Advancing gene therapies, methods, and technologies for Parkinson's Disease and other neurological disorders.
Fiandaca MS, Lonser RR, Elder JB, Zabek M, Bankiewicz KS, Neurol Neurochir Pol., 6/20/2020
GDNF and Parkinson's Disease: Where Next? A Summary from a Recent Workshop
Barker RA, Bjorklund A, Gash DM, Whone A, Van Laar A, Kordower JH, Bankiewicz K, Kieburtz K, Saarma M, Booms S, Huttunen HJ, Kells A, Fiandaca MS, Stoessl AJ, Eidelber..., J Parkinsons Dis, 6/9/2020
Author Correction: Plasma microRNA markers of upper limb recovery following human stroke.
Edwardson MA, Zhong X, Fiandaca MS, Federoff HJ, Cheema AK, Dromerick AW., Sci Rep., 2/9/2020